NMTC NeuroOne Medical Technologies Corporation Common Stock

XNAS 3.48 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

NMTC $3.48 —
Key stats
$3.48
52-Week Range
$0.77 – $6.12
YTD
-32.05%
Straddle Price
$3.42
P/C Vol Ratio
0.00
Market Cap
$0.0B
Open
$0.92
Day Range
$0.77 – $0.92
Volume
43,612
Prev Close
$0.92
Fair Value
MODEL: NEUTRAL

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.96%
Beta vs SPY0.82
Cost of Equity (CAPM)9.05%
WACC9.19%
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)-10.0%
DCF Horizon10 years explicit + fade
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)-197.6%
Book / Price13.9%
Gross Margin (TTM)66.3%
FCF Margin (TTM)-57.4%
Debt / Equity0.00
Quality Score2/6 — normal (10y DCF)
SMA 50$1.41 (Market Anchor value)
SMA 20 / Bollinger Mid$1.03
Bollinger Width / SMA203189.8% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: BDX, BSX, MDLN, SYK (filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
23%
20-Day Fair Value
≈ by Nov 25, 2026
$0.81
α +1.2% rank 56%
conviction
67%
40-Day Fair Value
≈ by Dec 24, 2026
$0.81
α +0.9% rank 62%
conviction
31%
60-Day Fair Value
≈ by Jan 22, 2027
$0.81
α +0.6% rank 56%
conviction
23%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 44.6× · 4 peers
Peer EV/EBITDA n/a 0% median 15.8× · 4 peers
Peer P/B $0.30 50% median 2.7× · 4 peers
Peer P/S $1.06 50% median 2.9× · 4 peers
Market Anchor (SMA50) $1.41 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-10-27 · updated
About
Industry (SIC)
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
18
List Date
2012-11-09
CIK
0001500198
Next Earnings
2026-12-15 (After-Close)
Headquarters
Eden Prairie, MN
Homepage
https://www.n1mtc.com

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation,…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan---2.99%0.69%-22.84%39.43%3.84%3.63%
Feb---4.76%14.18%-12.95%3.24%-19.70%-4.00%
Mar---43.59%3.21%-1.64%-20.54%16.42%-9.23%
Apr---28.70%-1.28%-5.04%-28.31%-2.33%-13.13%
May2.08%54.98%-26.22%-19.84%-1.12%-18.39%-1.42%
Jun-8.49%-43.77%2.56%-15.94%14.40%-18.28%-11.59%
Jul-29.94%40.54%-11.30%-15.50%11.73%-44.31%-8.13%
Aug-27.25%112.50%-19.76%10.76%0.82%0.00%12.84%
Sep14.83%-19.14%2.34%25.79%23.33%-36.02%1.85%
Oct-30.37%-38.30%-3.24%-2.99%-10.93%-18.39%*-17.37%
Nov-23.80%43.88%62.92%-33.71%-9.07%--8.04%
Dec-9.77%-16.08%8.97%27.08%11.29%--4.30%
Total-73.83%-41.74%10.91%-59.33%16.15%-81.61%-38.24%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $1.03
SMA 50: $1.41
SMA 200: $3.29
Current: $0.80
EMA 12: $0.98
EMA 26: $1.12
MACD: -0.1387 | Signal: 0.0015
BEARISH
ADX (14): 12.35
RANGE
+DI: 17.25
−DI: 26.32

Momentum Oscillators

RSI (14): 27.78
OVERSOLD
Stoch %K: 14.31
Stoch %D: 11.72
Williams %R: -91.65

Volume & Volatility

BB Upper: $1.20
BB Lower: $0.86
OVERSOLD
OBV: -15,527,318
Vol SMA 20: 176,054
Vol ROC: 9.20%
ATR: $0.12
True Range: $0.15
HV 20: 108.6%
HV 30: 93.5%
HV 60: 95.9%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

BULLISH (Confidence Level: 7/10)

Key drivers:

  • Strong recent revenue growth (105% Q3 increase)
  • Regulatory approval for sEEG RF ablation procedure code
  • Moderate volatility and correlation with market

Primary risks:

  • Nasdaq delisting risk due to share price issues
  • Unusual options activity may indicate insider buying or trading

Investment thesis: NMTC's recent revenue growth, regulatory approvals, and moderate volatility make it an attractive long-term investment opportunity.

Recent news sentiment impact: Positive news headlines have contributed to the stock's upward momentum.

Technical Analysis

Trend Direction: Medium-term uptrend (1-3 months)

Support/Resistance Levels:

  • SMA 20: $1.85
  • SMA 50: $2.09
  • Upper Bollinger Band: $2.27

Momentum Signals:

  • RSI: Neutral (40.06)
  • MACD: Bearish (-0.11 / -0.01 / -0.10)
  • Bollinger Bands: Neutral signal

Volume Analysis: Volume SMA 20 increasing, indicating growing institutional interest.

News & Sentiment Analysis

Recent Headlines Summary: Positive revenue growth and regulatory approvals are the primary drivers of the stock's upward momentum.

Sentiment Assessment: Overall sentiment is positive (66.7% of news headlines are positive).

Catalyst Identification: Upcoming earnings release may provide further catalysts or clarification on share price issues.

Market Narrative: News aligns with medium-term uptrend and moderate volatility, supporting the bullish case.

Risk & Volatility Assessment

Beta Interpretation: Low risk (beta 0.82 vs SPY), indicating a defensive stock.

Volatility Regime: Moderate volatility regime, with average true range of $0.26.

Options Market Signals: IV rank is medium-high (68.5%), indicating historically high volatility. Options market pricing a $2.35 move by expiration.

Downside Protection: Support levels include SMA 20 and Bollinger Band Lower ($1.43).

Market Context & Positioning

Sector Performance: NMTC's sector is outperforming the overall market, with a relative strength index of 62.5%.

Institutional Activity: Volume flow indicates growing institutional interest.

Correlation Analysis: Stock has a moderate correlation (0.13) with the broader market, suggesting some independence from market trends.

Relative Valuation: Position within trading range is moderate, indicating potential for further price movement.

Key Levels & Action Items

Critical Price Levels: SMA 20 ($1.85), SMA 50 ($2.09), and Bollinger Band Upper ($2.27) are key support and resistance levels.

Breakout/Breakdown Levels: A close above $2.27 could trigger a medium-term breakout, while a close below $1.43 could trigger a breakdown.

Time-Sensitive Catalysts: Upcoming earnings release (no date available).

Risk Management: Consider stop-loss levels at SMA 20 and Bollinger Band Lower for downside protection.

Please note that this report is based on the provided data and should not be considered as personalized investment advice.

Generated
Earnings History
12 of 13 under expected move
Avg Expected Move
236.29%
Avg Actual Move
5.65%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2022-02-14 After-Close 2.18% 13.75% 6.31x Exceeded
2023-12-14 After-Close 36.17% 11.05% 0.31x Within
2024-08-14 Pre-Market 657.89% 0.12% 0.00x Within
2024-12-17 After-Close 308.23% 6.41% 0.02x Within
2025-02-12 After-Close 445.45% 1.79% 0.00x Within
2025-05-13 After-Close 489.28% 2.48% 0.01x Within
2025-08-14 After-Close 328.31% 1.23% 0.00x Within
2025-10-06 After-Close 61.10% 6.47% 0.11x Within
2025-12-17 Pre-Market 88.43% 5.49% 0.06x Within
2026-02-17 After-Close 355.18% 0.16% 0.00x Within
2026-05-12 After-Close 100.80% 2.73% 0.03x Within
2026-08-13 Pre-Market 133.22% 20.39% 0.15x Within
2026-10-05 After-Close 65.54% 1.35% 0.02x Within

Earnings calendar: this week’s reports with expected vs actual moves →

NMTC Options Activity & IV Rank

Volatility Metrics

Current IV: —
7-DTE IV: —
Expected Move: $3.42
7-DTE Move: $3.42
Days to Exp: 25 (2026-11-20)

Options Flow

Call Volume: 9
Put Volume: 0
P/C Volume: —
BULLISH
Call OI: 14
Put OI: 0
P/C OI: —
Total OI: 14

ATM Options Pricing

ATM Call: $1.80
ATM Put: $1.62
Call %: 51.8%
Put %: 46.8%

Chain Summary

Chain Volume: 21
Chain OI: 150
Last Updated: 10/26/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Oct 23 · No data
30 DTE / 10d —
— pts EXTREME
as of Oct 23 · ATM 1429.9% / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)$3.42Oct 26
Beta Analysis

Risk Metrics

Beta: 0.7273
Alpha: -156.70%
Correlation: 0.1125
R-Squared: 1.3%
Stock Volatility: 82.4%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own NMTC
2 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Renaissance Technologies Hedge fund
Jim Simons
$215K
0.00%
#2867 of 3138-89.2%13F
Citadel Hedge fund
Ken Griffin
$46K
0.00%
#6023 of 6285new13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

NMTC Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 33,766,979 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

27 filers3,579,275 shares$7.27M value10.60% of float
# Filer Shares Value % of Total % of Float Period
1 Bleichroeder LP 666,666 $2.03M 27.87% 1.97% 2026-06-30
2 Vanguard Group Inc Custodian 1,578,237 $1.20M 16.45% 4.67% 2025-12-31
3 Vanguard Capital Management LLC 352,774 $1.07M 14.75% 1.04% 2026-06-30
4 BARD ASSOCIATES INC 305,428 $928.50K 12.77% 0.90% 2026-06-30
5 PERKINS CAPITAL MANAGEMENT INC 244,656 $743.75K 10.23% 0.72% 2026-06-30
6 Geode Capital Management, LLC Custodian 93,555 $284.45K 3.91% 0.28% 2026-06-30
7 Sio Capital Management, LLC 82,767 $251.61K 3.46% 0.25% 2026-06-30
8 RENAISSANCE TECHNOLOGIES LLC 70,861 $215.42K 2.96% 0.21% 2026-06-30
9 Vanguard Fiduciary Trust Co 49,018 $149.01K 2.05% 0.15% 2026-06-30
10 Cambridge Investment Research Advisors, Inc. 28,499 $87.00K 1.20% 0.08% 2026-06-30
11 BlackRock, Inc. Custodian 25,121 $76.37K 1.05% 0.07% 2026-06-30
12 Northern Trust Corp Custodian 21,398 $65.05K 0.89% 0.06% 2026-06-30
13 Citadel Advisors LLC Custodian 15,032 $45.70K 0.63% 0.04% 2026-06-30
14 Susquehanna International Group, LLP Custodian 13,520 $41.10K 0.57% 0.04% 2026-06-30
15 Belpointe Asset Management LLC 12,500 $38.00K 0.52% 0.04% 2026-06-30
16 Legato Capital Management LLC 10,273 $31.23K 0.43% 0.03% 2026-06-30
17 UBS Group AG Custodian 2,623 $7.97K 0.11% <0.01% 2026-06-30
18 Morgan Stanley Custodian 2,058 $6.26K 0.09% <0.01% 2026-06-30
19 Princeton Global Asset Management LLC 2,805 $2.89K 0.04% <0.01% 2026-09-30
20 Northwestern Mutual Wealth Management Co 361 $1.10K 0.02% <0.01% 2026-06-30
21 GK Wealth Management LLC 692 $713 <0.01% <0.01% 2026-09-30
22 Wells Fargo & Company Custodian 166 $505 <0.01% <0.01% 2026-06-30
23 Tower Research Capital LLC (TRC) Custodian 112 $340 <0.01% <0.01% 2026-06-30
24 Barclays PLC Custodian 76 $231 <0.01% <0.01% 2026-06-30
25 OSAIC HOLDINGS, INC. Custodian 58 $176 <0.01% <0.01% 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

NMTC Insider Trading (Form 4)

Latest: 2026-09-08
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-09-08 David J. Wambeke Chief Business Officer Buy (P) +33,333 $2.01 $67.0K EDGAR
2026-08-28 David A Rosa CEO & President Grant (A) +68,000 opt — EDGAR
2026-08-28 Christopher Volker Chief Financial Officer Grant (A) +35,000 opt — EDGAR
2026-08-28 Emily J. Johns Chief Administrative Officer Grant (A) +12,500 opt — EDGAR
2026-08-28 Mark Christianson Market Development Director Grant (A) +12,500 opt — EDGAR
2026-08-28 Steve Mertens Chief Technology Officer Grant (A) +15,000 opt — EDGAR
2026-07-02 Mark Christianson Market Development Director Sell (S) −10,000 $3.18 -$31.8K EDGAR
2026-04-07 Jeffrey S Mathiesen Director Award (A) +41,929 — EDGAR
2026-04-07 Edward Andrle Director Award (A) +41,929 — EDGAR
2026-04-07 Jason Richard Mills Director Award (A) +41,929 — EDGAR
2026-04-07 Paul Buckman Director Award (A) +41,929 — EDGAR
2026-04-01 David A Rosa CEO and President Tax (F) −2,458 $0.78 -$1.9K EDGAR
2026-04-01 Mark Christianson Business Development Director Mixed −15,616 $0.74 -$11.6K EDGAR
2026-04-01 Steve Mertens Chief Technology Officer Tax (F) −906 $0.78 -$704 EDGAR
2026-03-16 Mark Christianson Business Development Director Sell (S) −917 $0.80 -$734 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

NMTC Insider Holdings

10 insiders · @ $0.80
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 David J. Wambeke Chief Business Officer 199,999 $160.8K $737.4K 2 2026-09-08
2 David A Rosa CEO & President 180,022 $144.7K $50.0K 41 2026-08-28
3 Ronald W. McClurg Chief Financial Officer 74,020 $59.5K $200.2K 10 2025-04-21
4 Paul Buckman Director 29,789 $23.9K $0 7 2026-04-07
5 Jeffrey S Mathiesen Director 26,057 $20.9K $0 6 2026-04-07
6 Steve Mertens Chief Technology Officer 25,357 $20.4K $0 39 2026-08-28
7 Edward Andrle Director 22,322 $17.9K $0 6 2026-04-07
8 Mark Christianson Market Development Director 20,692 $16.6K -$391.9K 53 2026-08-28
9 Christopher Volker Chief Financial Officer 12,500 $10.0K $105.0K 4 2026-08-28
10 Jason Richard Mills Director 8,281 $6.7K $0 2 2026-04-07
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

NMTC Board & Officers

As of SEC filings through Sep 8, 2026

Directors 5

Officers 6

10% owners 1

Changes in the last 10 years (34)
Jul 10, 2026Brian Pratt became a 10% owner
Jul 2, 2026Mark Christianson listed as Market Development Director (previously Business Development Director) in SEC filings
Mar 1, 2026David J. Wambeke became Chief Business Officer
Dec 18, 2025Jason Richard Mills became a director
Jun 1, 2025Emily J. Johns became General Counsel
Nov 10, 2023Christopher Volker became Chief Operating Officer
Jun 25, 2021Mark Christianson listed as Business Development Director (previously VP, Business Dev and Marketing) in SEC filings
Apr 26, 2021Hijaz Haris became VP of Marketing
Jan 15, 2021Morgan C. Frank became a 10% owner
Jan 15, 2021Manchester Management Pr, LLC became a 10% owner
Jan 15, 2021Manchester Management Co LLC became a 10% owner
Jan 15, 2021Manchester Explorer, L.P. became a 10% owner
Jan 15, 2021James E Besser became a 10% owner
Jan 1, 2021Ronald W. McClurg became Chief Financial Officer
Jun 16, 2020Mark Christianson no longer listed as a 10% owner in SEC filings
Feb 18, 2020Edward Andrle became a director
Nov 7, 2019David A Rosa no longer listed as a 10% owner in SEC filings
Nov 7, 2019David A Rosa listed as CEO and President (previously Chief Executive Officer) in SEC filings
Apr 4, 2019Mayo Foundation for Medical Education & Research reported in an SEC filing no longer being a 10% owner
Apr 1, 2019Steve Mertens became Chief Technology Officer
Not reported recently (14)
  • Ronald W. McClurg · Last reported as Chief Financial Officer in an SEC filing dated Apr 21, 2025
  • Hijaz Haris · Last reported as VP of Marketing in an SEC filing dated Apr 28, 2021
  • James E Besser · Last reported as a 10% owner in an SEC filing dated Jan 21, 2021
  • Manchester Explorer, L.P. · Last reported as a 10% owner in an SEC filing dated Jan 21, 2021
  • Morgan C. Frank · Last reported as a 10% owner in an SEC filing dated Jan 21, 2021
  • Manchester Management Co LLC · Last reported as a 10% owner in an SEC filing dated Jan 21, 2021
  • Manchester Management Pr, LLC · Last reported as a 10% owner in an SEC filing dated Jan 21, 2021
  • Suraj Kalia · Last reported as a director in an SEC filing dated Nov 7, 2019
  • Wade Fredrickson · Last reported as a 10% owner in an SEC filing dated Oct 23, 2019
  • Scott Heuler · Last reported as Vice President of Sales in an SEC filing dated Mar 1, 2019
  • Amer Samad · Last reported as a director in an SEC filing dated Aug 7, 2017
  • Lifestyle Healthcare LLC · Last reported as a 10% owner in an SEC filing dated Jul 26, 2017
  • Thomas Bachinski · Last reported as Chief Development Officer in an SEC filing dated Jul 24, 2017
  • Chromium 24 LLC · Last reported as a 10% owner in an SEC filing dated Jul 13, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

NMTC Proposed Insider Sales (Form 144)

Latest: 2026-06-30
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-06-30 Christianson Mark Officer 10,000 $33.4K 2026-06-30 Edward Jones — EDGAR
2026-03-09 Christianson Mark Officer 30,000 $25.2K 2026-03-09 Edward Jones — EDGAR
2025-08-20 Christianson Mark Officer 30,000 $24.2K 2025-08-20 Edward Jones — EDGAR
2025-03-14 Christianson Mark Co-Founder, VP of Business Communication,Affiliate 30,000 $30.6K 2025-03-14 Edward Jones — EDGAR
2024-05-24 Christianson Mark co-founder, VP of Business Communication, Affiliat 30,000 $32.7K 2024-05-24 Edward Jones — EDGAR
2023-12-21 Christianson Mark Officer 50,000 $69.0K 2023-12-21 Edward Jones — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
3 ETFs hold NMTC
3 shown · $375.28K total exposure · 0.00% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $262,586 — 2026-09-30
2 VXF Vanguard Extended Market ETF Vanguard 0.00% $92,824 — 2026-09-30
3 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.00% $19,870 $1.2B 2026-10-23
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-1.64
TTM Revenue
$12.47M
TTM Net Income
$-7.45M
TTM Op. Cash Flow
$-7.05M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q3 '262026-06-30$1.97M$-2.01M$-0.28$-1.08M
Q2 '262026-03-31$2.39M$-2.09M$-0.25$-1.33M
Q1 '262025-12-31$2.89M$-1.44M$-1.08$-3.12M
Q4 '252025-09-30$5.74M$-1.62M$-1.44$-1.53M
Q3 '252025-06-30$1.70M$-1.50M$-0.19$-1.46M
Q2 '252025-03-31$1.39M$-2.27M$-0.44$-56.14K
Q1 '252024-12-31$3.27M$1.79M$2.16$208.05K
Q4 '242024-09-30$272.28K$-3.35M$-3.96$-2.67M
Q3 '242024-06-30$825.78K$-2.77M$-3.60$-2.36M
Q2 '242024-03-31$1.38M$-2.86M$-3.96$-2.18M
Q1 '242023-12-31$977.65K$-3.34M$-5.04$-3.81M
Q4 '232023-09-30$741.78K$-3.14M$-4.68$-2.90M
Q3 2026 • period ending 2026-06-30 • filed 2026-08-13
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
7.21
P/S
2.18
EV/EBITDA
—
EV/Sales
2.01
ROE
-197.6%
ROA
-120.4%
Div Yield
0.00%
FCF Yield
-25.98%
Debt/Equity
0.00
Current Ratio
—
Market Cap
$27.15M
as of 2026-10-26
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
178.73K
SI % of Float
2.46%
Days to Cover
1.19
Short Vol Ratio
56.6%
Free Float
7.28M
Float %
79.9%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-08-13